In addition to the noted effects of hormone receptors on the oncogenic signaling pathway in tumor development and progression, emerging data suggest that these receptors can also modulate effects on tumor metabolism and metabolic reprogramming in HR+ breast cancer [19,20,21,59]. The gene discussed is NR4A1; the disease is neoplasm.